Introduction
The env gene of human immunodeficiency virus type 1 (HIV-1) contains several predicted antigenic determinants, the majority of which are found in the five hypervariable regions (V1 to V5) of the portion encoding gpl20 (Starcich et al., 1986; Modrow et al., 1987) . The third hypervariable region of env, V3, carries the principal neutralization-specific epitope (Palker et al., 1988; Javaherian et al., 1989) and also a cytotoxic T cell epitope (Hoffenbach et al., 1989; Takahashi et al., 1989) . V3 neutralization escape mutants from both experimentally infected chimpanzees and humans may arise not only by genetic changes within this region but also by
The nucleotide sequences presented in this paper have been submitted to the GenBank database and assigned the accession numbers L26408 to L26445. genetic change in other areas (McKeating et al., 1989 : Albert et al., 1990 Nara et al., 1990) . Sequence analysis of a haemophiliac cohort in Edinburgh suggested that sequence variation in the V3 region and in the fourth and fifth variable regions, V4 and V5, was in part generated by natural selection (Balfe et al., 1990; Simmonds et al., 1990b) . These studies also showed that plasma viral RNA variants preceded those found as proviral DNA in the peripheral blood (Simmonds et al., 1991) . The V3 region of env has also been linked to cell tropism and viral pathogenesis Liu et al., 1990; Hwang et al., 1991 ; Collman et al., 1992; Fouchier et al., 1992; Kuiken et al., 1992; Westervelt et al., 1992) and was found to be involved in the ability to infect brain-derived fibroblasts (Takeuchi et al., 1991 ) and brain microglial cells (Sharpless et al., 1992) .
The existence of genetically distinct HIV isolates within individuals (the 'quasispecies') has been demonstrated frequently : Saag et al., 1988 ; Meyerhans et at., 1989; Wain-Hobson, 1989; Balfe et al., 1990; Simmonds et al., 1990b; Wolfs et al., 1990; Martins et al., 1991 ; Oram et al., 1991 ; Simmonds et al., 1991) , and these quasispecies fluctuate over time. Differences in the distribution of HIV variants between mononuclear cells and blood plasma at the same timepoint have been reported (Simmonds et at., 1991) , whereas differences between blood-and brain-derived sequences (Epstein et al., 1991) , and more recently spleen-and blood-derived sequences, have also been observed (D~lassus et aI., 1992) . It has been shown previously that the virus population can be greatly disturbed during culture; very often the sequences present after co-cultivation demonstrate less variability and may even be distinct from the in vivo population (Meyerhans et al., 1989; Kusumi et al., 1992) .
The studies presented here were carried out to assess whether distinct HIV-1 variants can co-exist in different organs and body fluids at the same time and whether reactivation of some of these variants could account for the fluctuating nature of the peripheral blood viral and proviral quasispecies. Therefore, hypervariable regions of HIV-1 env gene from proviral DNA of different organs and viral RNA (plasma) obtained after death from three patients, and from two sequential blood samples obtained from one of these patients before death were investigated. Attempts were made to adapt viruses obtained from the two sequential blood samples taken before the patient's death to growth in tissue culture. The biological phenotype and consensus V3 loop sequences of these isolates were determined.
Methods
Patient samples. Sequential peripheral blood samples, taken 13 and 10 months before death (denoted E21 and E21a, respectively) and samples taken at autopsy (E21b; Ball et al., 1991) were obtained from (Simmonds et al., 1990a Virus culture. Lymphocytes were obtained from sequential blood samples collected in EDTA and co-cultivated with phytohaemagglutinin-stimulated umbilical cord blood lymphocytes (CBLs) as described previously (von Briesen et al., 1987; Farrar et al., 1991) . Viral growth was monitored by c.p.e, and p24 antigen production using a commercial kit (Coulter). Cell-free supernatant from CBL-positive cultures was used to infect the JM cell line (Farrar et al., 1991) .
DNA extraction. Extraction was either by the sarcosyl proteinase K-phenol method described previously (Simmonds et al., 1990a) , or the use of a commercially available extraction kit (Stratagene). Samples were precipitated with ethanol at room temperature and the resulting DNA pellets were resuspended in 25 to 500 pl of distilled water. All extractions were carried out using positive-displacement pipettes (Gilson, Anachem).
RATA extractton from plasma and reverse transcriptase-mediated eDNA synthesis. RNA extraction from 50 to 200 gl of plasma was carried out using the guanidinium isothiocyanate and acid phenol procedure as described previously (Chomczynski & Sacchl, 1987) . RNA was recovered by ethanol precipitation and resuspended in 50 pl 50 m~-Tris-HC1 buffer pH 7.5 containing 1 mM-EDTA, 10 m~-MgCl~, 1 mM-DTT and 5 units of RNasin (Promega). This sample was incubated at 37 °C for i h, then EDTA and SDS were added to final concentrations of 10 mM and 0.2 %, respectively, followed by extraction wtth phenol-chloroform and ethanol precipitation in the presence of 0.3 M-sodium acetate.
eDNA synthesis was based on the procedure described by Kawasaki (1990) . The RNA sample (5 BI) was used in a reverse transcriptase (RT) reaction (25 gl) containing 800 gM-deoxynucleotldes (dATP, dCTP, dGTP and dTTP), 10 ng of antisense primer 504 (see below), in 50 mMTri~HC1 buffer pH 8.3. 8 mM-MgC12, 50 mM-KCI, 10 mM-DTT and 10% DMSO. The reactions were heated to 92 °C for 2 rain, rapidly cooled on dry ice--ethanol, then 6 units of avian myeloblastosis virus RT (Promega) and 5 units of RNasin (Promega) were added. Reactions were carried out for 1 h at 42 °C. Negative control reactions consisting of RNA template, no RT and no template plus RT were carried out in parallel. sequential peripheral blood samples (E21, E21a) and cardiac blood and various organs obtained at autopsy (E21b) from the same patient, and in autopsy specimens from patients E44a and E25. M, 1 kb DNA size markers; Ca, cardiac blood; LN, lymph node; Sp, spleen; BM, bone marrow; Br, brain: n, umbilical cord blood DNA-negative controls. The sizes (nucleotides) of three DNA size marker bands are shown in (a). Samples in (b) and (c) were loaded in the same order as shown in (a).
Amplificatton of the V1/V2, V3 and V4/V5 regions for analysis of length polymorphism. Portions of sample DNA containing greater than 50 to 100 molecules of proviral DNA were used as a template in a nested-primer PCR. DNA samples were boiled for 5 rain and then used in an initial reaction using primers 401 and 504. The PCR parameters were 30 cycles of 94 °C for 1 min, 55 °C for 1 rain and 72 °C for 4 min (Techne PHC-2). A 1 gl sample of the product from this reaction was used as a template in three separate reactions using either primers 402 and 403, 306 and 307 or 502 and 503 in order to amplify the regions V1/V2, V3 and V4/V5, respectively. These second-round PCRs were carried out using 10 ~tM of each dNTP with the addition of 1 laCi [~SS]dATP (1000 Ci/mmol; Amersham) per reaction. Cycling parameters were 94 °C for 1 rain, 55 °C for 1 min and 72 °C for 3 mln. Analysis of samples containing very low amounts of provirus was achieved by carrying out multiple first-round reactions, which were then pooled, and a sample of this served as a template in the secondround reaction. One Ixl of 1 kb DNA ladder size markers (100 ng: Gibco BRL) was labelled using 1 laCi of [3~S]dATP (1000 Ci/mmol), 50 laM-dCTP, -dGTP and -dTTP and 0.5 units of Amplitaq in 20 lal of PCR buffer at 70 °C for 5 ruin. An equal volume of a mixture containing 95 % formamide, 10 mM-EDTA, 0-1% bromophenol blue and 0.1% xylene cyanol was added to the labelled PCR products and these were analysed using denaturing PAGE as described previously (Simmonds et al., 1990a, b) .
Estimates of the frequency with which the variants occurred within the sample were made by scanning densitometry. The sizes of the PCR products were estimated by interpolation from standard curves derived from the mobility of the 1 kb standard markers plotted against their size in number of nucleotides.
PCR amplification of the V3 region of single proviral DNA molecules.
Equivalents of 0.5 molecules of DNA or cDNA determined by endpoint titration (Simmonds et al., 1990a, b, 19917 were used as the template in a PCR using primers 401 and 504. One pl of this product served as template in a second PCR using primers 306 and 307 to amplify across the V3 region. In some second-round reactions primer 307dv , which contained dUTP instead of dTTP, was used instead of primer 307. This allowed uracil-N-glycosylase digestion of the primer following thermal cycling to enable rapid purification of the products before sequencing as described previously (Ball & Desselberger, 1992 a) . The sensitivity of the nested primer procedure was assessed using standards obtained from the PCR reference laboratory at the National Institute of Biological Standards and Control (London, U.K.); it could consistently detect single HIV DNA molecules as demonstrated by agarose gel electrophoresis (results not shown).
Amplification of the V3 region of tissIw culture-grown vtrus.
Approximately 1 lag of DNA extracted from CBL-and JM cell-virus co-cultures was used as a template in the nested primer PCR described above.
Sequencing of 1/3 PCR products. Final PCR products were purified using either the Isogene kit according to the manufacturer's instructions (Perkin-Elmer Cetus) or by uracil-N-glycosylase digestion of incorporated and unincorporated dU-contaiuing primer 3070v followed by ethanol precipitation as described previously (Ball & Desselberger, 1992a) . Sequencing was carried out using the Sequenase version 2 kit (USB) with the following modifications, Purified PCR product (5.5 lal) was added to 1 lal of primer 306 (1 pmol), 1-5 Ixl DMSO and 2 ~tl of 5 × annealing buffer (200 mM-Tris-HC1 pH 7.5, 100 mM-MgCI~, 125 mra-NaC1), boiled for 2rain and then rapidly cooled on dry ice-ethanol (Winship, 1989) . To this were added 1 lal 100 mM-DTT, 2 lal of'labelling' nucleotides (1"5 p.M-dGTP and dTTP) (Tsang & Bentley, 1989) , 0.2 laCi [3~S]dATP and 2pl of Sequenase (0.1 unlt/lal) in Tris-HC1 buffer pH 7.4 containing 10 mM-DTT. The rest of the reaction was carried out as described by the manufacturer and analysed using denaturing PAGE as described previously (Sambrook et al., 1989) . Some sequence reactions gave premature enzyme stop signals.
These were overcome by using 250 ng of Escherwhia coli ssDNAbinding protein (ssbp) in the primer annealing step. The protein was degraded prior to gel electrophoresis by the presence of 0.5 Mguanidinium isothiocyanate (BDH) in the stop mix (Ball & Desselberger, 1992b ).
Phylogenetic analysis. An unrooted phylogenetic tree for all 124 V3 nucleotide sequences obtained from sequential blood samples, cardiac blood, lymph node, bone marrow, plasma and brain was constructed using the neighbour-joining method of Saitou & Nei (1987) available in the program NEIGHBOR from the PHYLIP package (version 3.4) of Felsenstein (19917. Distances between each pair of sequences were estimated using the program DNADIST with the available options set to use an evolutionary model that allows different frequencies of transition and transversion and different frequencies of the four bases (Felsenstein, 1991) . In order to assess the reliability of the major groupings observed in the analysis of the full data set, further phylogenetic analysis was performed on the 38 unique V3 sequences found across all samples using the maxmaum likelihood method (program DNAML) and the neighbour-joining clustering method with (78) 292 ( 
Results

Estimation of proviral load
The proviral copy number for the various sequential blood and autopsy-derived samples, as estimated by endpoint dilution followed by Poisson distribution analysis (Simmonds et al., 1990a) , is presented in Table  1 . The blood proviral load of the CDC stage III patient (E25) was much lower than that of the other two patients (E21, E44a) who were in the symptomatic phase of infection (CDC stage IV). The viral load within the brains of the three patients differed greatly, with samples from both patients E25 and E44a containing approximately 0"5 molecules in the DNA in approximately 150000 cells (1 gg) whereas patient E21b had a brain viral load in excess of 200 copies per 150 000 cells. Where tested, the lymph nodes contained at least fivefold more proviral DNA than the corresponding blood sample, although no trend was observed for spleen or bone marrow estimates.
Length polymorphism analysis
DNA extracted from cardiac blood, lymph node, spleen, bone marrow and brain was subjected to nested-primer PCR to amplify the regions V1/V2, V3 and V4/V5, and the length variants present were analysed (Fig. 1 , Table   2 ). The lengths of PCR products corresponding to regions VI/V2 and V4/V5 for samples from E21, E21a, the blood, spleen and lymph node of E21b and samples from E44a were very similar within patients. Patient E44a harboured shorter length variants in both regions compared with E21, E21a or E21b. Differences in the abundance and size of the less frequent V1/V2 and V4/V5 length variants between the sequential blood samples from E21 and E21a and samples from the periphery of E21b were also observed. In contrast, the variants present in the brain of sample E21 b were unique, with both regions containing shorter variants than those observed in either the sequential blood or peripheraltissue autopsy samples. However, this was not so in patient E44a; in this case the most frequent PCR products obtained from the brain were identical to the variants found in the periphery. Finally, the samples of patient E25 were composed of a more diverse population of length variants. In particular, major length variants found in the peripheral blood differed in both size and frequency from those found in the lymph node. Again, unlike patient E21b, the length variants present in the brain from this patient were also found in the other samples.
A similar analysis of the V3 region demonstrated that the sequential blood samples (21, 21a) and the lymph node, spleen and bone marrow of patient E21 b contained a less frequent, larger length variant which was not present in the blood sample obtained at autopsy. The estimated size difference for the two length variants present in E21, E21a and the E21b lymph node and bone marrow samples was nine nucleotides. By analysing separate aliquots from these samples the results were shown to be reproducible. For example, a second aliquot of samples from patient E21b contained V3 variants of lengths 318 (23% lymph node, 16% spleen and 15% bone marrow) and 309 nucleotides (100% cardiac blood, 77% lymph node, 84% spleen, 85 % bone marrow and 100 % brain) at the frequencies indicated, which are similar to those shown in Table 2 .
V3 sequence analysis of single molecules obtained in vivo
As important cytotoxic T cell and B cell epitopes of HIV-1 have been located within the V3 region in addition to determinants of cell tropism and cytopathogenicity, this region was analysed in more detail. The sequential blood and autopsy samples obtained from patient E21 were chosen for further study to assess the potential role of persistence of HIV-1 variants within lymph tissue after their disappearance from the peripheral bloo& as suggested by the length polymorphism analysis. Between 11 and 20 single proviral or cDNA molecules per sample were obtained by PCR amplification at endpoint dilution and then dirctly sequenced (Balfe et al., 1990; Simmonds et al., t990a, b) . The unique nucleotide sequences are presented in Fig. 2 and Table 3 (terminal gaps in some sequences derived from E21a were omitted in constructing Fig. 2) ; the deduced amino acid sequences are shown in Fig. 3 . The two cysteine residues, which are joined via a disulphide bridge to form the V3 loop, are indicated by an asterisk. In 40% and 64% of the V3 regions of DNA from sequential blood samples E21 and E21a, respectively, the conserved apical tetrapeptide, GPGR, (Balfe et al., 1990; La Rosa et al., 1990; Epstein et al., 1991) was present. The other V3 sequences contained an unusual loop apex of GPGS and an additional GPG insertion at the amino side of the loop apex. The variants with unusual apex loops also contained several additional amino acid changes within the loop, such as serine to phenylalanine at position 25 and alanine to threonine at position 39. Sequences characterized by the loop apex insert were absent from the blood obtained at autopsy. The most frequent (95 %) loop apex motif was GPGR but in 5 % of the sequences a G ~ A transition was responsible for mutating the loop apex to RPGR. However, sequences containing the unusual GPGS and tripeptide insert were found within the lymph node (15 %) and bone marrow (20 %) samples. In 5 % of sequences from the bone marrow a G-+ A transition at the loop apex had mutated the second glycine residue to a glutamine residue (sequence 12, Fig.  2) .
The brain samples contained a third distinct apical tetrapeptide sequence of GPGG and additional unique changes elsewhere, for example threonine to serine at position 10 and isoleucine to leucine at position 28. The brain variant nucleotide sequences showed little variation in the V3 region (sequences 37 and 38; Fig. 2, Table 3 ), the only mutation present being silent (Fig. 3) .
The most frequent variant in the plasma virion cDNA population (45%) was also found at high frequency in most of the other post-mortem samples (sequence 1 ; Fig.  2 ). The second-most frequent plasma sequence (20%) contained a silent T ~ A transversion, and this sequence was absent from the corresponding cardiac blood proviral population but was found fi'equently in the lymph tissue and sequential blood samples obtained before death (sequence 2; Fig. 2 Fig. 3 . Deduced amino acid sequences of the V3 region of proviral molecules from sequential peripheral blood samples E21 and E2 la obtained before death and cardiac blood (E21b CAB), lymph node (E21b LN), bone marrow (E21b BM) and brain (E21b Br) and of viral RNA molecules obtained from plasma (P1) of the same patient at autopsy. Between 11 and 20 sequences per sample were determined. The frequency of each sequence in a sample is recorded as a percentage. Dots indicate identity and dashes amino acid deletions. The cysteine residues which are linked via a disulphide bridge to form the loop are indicated by asterisks and correspond to positions 296 and 330 from the start of the env gene of the pHXB2r clone of HIV-1I~TLv_~IIB (Myers et al., 1991) . Amino acids previously identified as determinants of cell tropism and cytopathogenicity are indicated by • (Westervelt et al., 1992) and ~ (Fouchier et al., 1992) .
variant (5 %) was present in the plasma cDNA which contained the atypical loop apex and nucleotide insertion. No sequences corresponding to the brain variant were found in the plasma. If the most frequent variant found across all samples is taken as the reference sequence, then approximately 67% and 45% of the nucleotide changes were silent in the viral and proviral autopsy blood populations, respectively (Fig. 2) .
Phylogenetic analysis of the in vivo V3 data set
An unrooted neighbour-joining tree was constructed using all 124 (total V3 data set) V3 sequences obtained from patient E21 (E21, E21a and E21b) and is shown in Fig. 4 . Three distinct groups, labelled A, B and C, were apparent. These three groups were also clearly separated in a maximum likelihood analysis of the 38 unique V3 sequences from all samples and by significant numbers of bootstrap replicates of neighbour-joining trees (percentages supporting the relevant branches are shown in Fig.  4 ). Group A contains the sequences obtained from lymph node, bone marrow, plasma and all blood samples which contain the GPGR motif. Group B contains sequences from lymph node, bone marrow, plasma and pre-mortem blood samples which possess the tripeptide insert and the GPGS tetrapeptide. Finally, group C contains the highly homogeneous set of sequences obtained from the brain. The only sequence that appears to fall outside of these three groups is one obtained from 21b cardiac blood, although it does have three amino acid substitutions in common with sequences containing the tripeptide insert (Fig. 3) . These groupings were also evident in the neighbour-joining tree derived from the 22 unique amino acid sequences (not shown). The mean percentage sequence distances within and between each organ/body fluid, as estimated by the program DNADIST, are presented in Table 4 . The 20 sequences derived from the brain are the most homogeneous, with a mean pairwise distance of only 0"06 %.
The remaining samples are substantially more diverse, particularly pre-mortem blood sample E21a which has a mean pairwise distance of 4.33%. The post-mortem blood sequences show a decline in genetic variability, primarily because they lack sequences that contain the tripeptide insert. Finally, although the plasma contains sequences assigned to both groups A and B, the population of sequences is still relatively homogeneous (mean pairwise distance of 1.57 %).
Sequence analysis of the V3 loops of tissue cultureadapted E21 and E21a isolates
Virus from both samples induced syncytium formation in primary CBL cultures, produced detectable amounts of p24 antigen and was easily transmitted to the JM cell line (Fig. 5) . Direct sequencing of the V3-specific PCR products obtained after amplification of a 1 ~tg DNA sample was carried out to give the majority (or consensus) sequence within the samples (Fouchier et al,, 1992 tripeptide insert (Fig 2) , are shown in Fig 4 Both E21 cultures were identical in sequence but differed from the majority in vivo culture at one position (Glu-> Ala). This variant was absent from the entire #t vivo data set (Fig.  2) . By contrast, the sequences present in the E21a cultures were identical to the most frequent in vivo sequence containing the tripeptide insert and atypical loop apex.
Discussion
The results presented here indicate that different variants co-exist within different organs and body fluids at the same time and in the same host. Differences between CNS-derived and other HIV isolates from blood in some, but not all, infected individuals have been described (Koenig et al., 1986; Koyanagi et al., 1987; Chiodi et al., 1988; Epstein et al., 1991; Pang et al., 1991) . Provirus from the brain of E21b contained a mutated V3 loop apical sequence of GPGG, and changes within this region have previously been associated with changes in cell tropism (Takeuchi et aL, 1991) . The proviral load within the brain of patient E21b was significantly greater than that in either of the other two patients. At autopsy the brain from patient E21b demonstrated signs of encephalopathy whereas those of the other two patients did not. The variants present within this patient's brain also differed in length and sequence composition compared with those from the other sample sites. In contrast, the most frequent length variants from the brains of the two patients with a low copy number of virus could be found within samples obtained from other sites of the body. Findings from another study showed that in only one of three patients was there evidence for independent evolution between sequences obtained from lymph and brain tissue; estimations of the viral load were not available (Epstein et al., 1991) . We therefore suggest that true neurotropic virus isolates are found in only a limited number of individuals; these are able to grow to high titres and are likely to evolve independently, therefore becoming genetically distinct from the variants found in lymph tissue and blood. This will be further investigated by estimation of viral load and sequence analysis of brain samples from patients demonstrating normal as well as abnormal brain pathology.
Most, but not all, of the V3 variants found in the lymph node, bone marrow and plasma and not blood provirus at the time of death, were present in the sequential peripheral blood samples obtained before death (e.g. sequence 2; Fig. 2, Table 3 ). The lymph and bone marrow tissues therefore appear to be acting as a reservoir for HIV variants, enabling them to persist within the infected host. These variants may, under suitable conditions (e.g. changing immune status), reenter the peripheral circulation giving rise to the fluctuating pattern of the peripheral quasispecies (Meyerhans et al., 1989; Wain-Hobson, 1989) .
Circulating memory T cells (CD45RO ÷) have been shown to be the predominant reservoir for HIV-1 in the peripheral blood (Schnittman et al., 1990) . More recent studies have shown that in secondary lymph tissue, such as lymph nodes, cells harbouring the majority of provirus appear to be T helper cells and to a lesser extent macrophages/monocytes, of which only a small pro-portion actively produce virus (Embretson et aI., 1993; Pantaleo et al., 1993) , After infection, during the initial viraemia or during the asymptomatic phase, many different genotypes of HIV may arise due to the high error rate of the viral RT (Takeuchi et al., 1988) . Although population heterogeneity, particularly in the env gene, is dramatically reduced in the peripheral blood at primary infection (Wolfs et al., 1992; Zhang et al., 1993) diverse virus populations may be transmitted to, or be locally produced within, organs such as lymph node, spleen and bone marrow. Within these organs, during the asymptomatic phase, large amounts of virus, produced by transcriptionally active sequestered T4 cells, are trapped on the surfaces of follicular dendritic cells (FDCs). When the FDC network starts to break down late in infection, variants released from the FDCs would be disseminated to other lymphoid organs, trapped by FDCs, thus infecting more T helper cells as they are released into the peripheral circulation. This would ultimately result in reinfection of monocytes and T helper/memory cells within the germinal centres as the lymphocytes return to the lymph tissue (Embretson et al., 1993; Pantaleo et al., 1993) . This phenomenon would explain the temporal and spatial differences observed between blood and secondary lymph tissue sequences observed in this and other studies (D~lassus et al., 1992) , as well as the phenomenon of sequences present as free virus in the plasma preceding the predominant proviral sequence in the circulating PBLs (Simmonds et al., 1991) .
In an attempt to correlate the non-homogeneous distribution of sequences within the different autopsy samples with cell tropism and cytopathogenicity, the overall charges of the V3 loops were estimated and found to be greater than + 3 for all in vivo and h7 vitro variants. This would suggest the presence of syncytium-inducing variants (Fouchier et aL, 1992; Kuiken et al., 1992; de Jong et at., 1992a , b: Milich et al., 1993 . To investigate this further, specific amino acids present at sites previously identified as influencing these phenotypes were analysed. Tyrosine (position 38 ; Fig. 2 ) was present in all sequences and correlates with macrophage tropism, whereas the amino acids at position 27 (Fig. 2) are either arginine (non-monocytotropic) in sequences containing the tripeptide insert or histidine (monocytotropic) in sequences lacking the insert (Westervelt et al., 1992) . The amino acids present at position 42 are either acidic, negatively charged or uncharged, whereas the residues at position 25 are uncharged, indicating non-syncytium inducing, monocytotropic variants (de J ong et al., 1992 b; Fouchier et al., 1992; Westervelt et al., 1992) . A similar analysis of the tissue culture-adapted virus predicted that the isolates should be macrophage-tropic, non-syncytium inducing isolates (de Jong et al., 1992b; Fouchier et al., 1992; Westervelt et al., 1992) predicted from positions 25, 38 and 42 (Fig. 4) . However, the arginine residue at position 27 would predict non-monocytotropic isolates (Westervelt et al,, 1992) . Attempts to transfer the virus from patient 21 CBL cultures to the monocytic cell line U937 were not successful (results not shown). It would therefore appear that the phenotype may, in some isolates, have more complex determinants than suggested by the analysis of the charge/pKa of amino acids at defined positions of the V3 loop. Recent studies have shown that the replicative capacity of monocytotropic isolates is also influenced by changes in other regions of the env gene (Chesebro et al., 1992; Milich et al., 1993) .
The changes observed in the carboxy-and aminoterminal regions of V3 may alter the cytotoxic T cell and B cell determinants and possibly the cell tropism of these viruses (Javaherian et al., 1989; Hoffenbach et al., 1989; Takahashi et al., 1989; Epstein et al., 1991) . Therefore, immune selective pressure (or its removal), restraints in cell tropism or possibly the start of AZT therapy between samples E21 and E21a may be responsible for the reduction in genetic variation observed within the proviral and post-mortem blood virus population and the absence of heterogeneity in the brain virus population. A low intra-strain variability for brain isolates (Li et al., 1991) and homogeneity and convergent evolution of V3 proviral and plasma RNA populations (Simmonds et al., 1991; Holmes et al., 1992) have been reported previously. The most frequent nucleotide substitutions observed were G-+A transitions, as has been reported elsewhere (Martins et al, 1991 ; Vartanian et al., 1991) . In the studies presented here there was more variation observed in the env gene within the CDC stage III patient (E25) than the symptomatic patients. This may represent outgrowth of the variants with a greater replicative ability or pathogenic potential during the final stages of the disease.
The persistence of variants containing the insert within the bone marrow and lymph nodes of patient E2lb may indicate that the virus exists in a latent form in cells such as CD45RO + cells, or is expressed in chronically infected macrophages/monocytes. Cells producing HIV-1 would serve as targets for functioning antibody-dependent and -independent cytotoxic T cell responses (Hoffenbach et al., 1989 ; Koup et al., 1991) . However, from these studies it is unclear whether T4 cells (either the CD45RO + or the CD45RO-subset), or cells of the macrophage/monocyte lineage are responsible for the persistence of the unique V3 variants within the lymph node and bone marrow.
The results presented here indicate that different variants co-exist within different organs and body fluids at the same time in the same host. The accumulation and persistence of genetically distinct variants within lymph tissue and brain may have a very important role in the overall pathogenesis of the disease. Therefore, analyses of the viral populations present within different organs and body fluids should not be overlooked if effective vaccines or treatments are to be developed.
